Health care pharmaceutical companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Grifols has the lowest figure of the 50 health care pharmaceutical companies ranked by P/S ratio, at 0.7, followed by Viatris (1.6) and GSK (2.2). Figures as of 20 Nov 2026, 03:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 50
- Lowest
- Grifols0.7
- Median
- 6.7
- Combined market value
- NOK 48.44T
- Countries
- 10
- Not ranked
- 11no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | GrifolsGRFS · Health Care | 0.7 | NOK 54.5B | NOK 80.04 | 3.19% down | 0% up | ||
| 2 | ViatrisVTRS · Health Care | 1.6 | NOK 222.5B | NOK 194.05 | 1.97% down | 99% up | ||
| 3 | GSKGSK · Health Care | 2.2 | NOK 935.6B | NOK 466.77 | 1.56% down | 5% up | ||
| 4 | SanofiSNY · Health Care | 2.3 | NOK 1.08T | NOK 449.59 | 2.25% down | 4% down | ||
| 5 | Takeda PharmaceuticalTAK · Health Care | 2.4 | NOK 667.7B | NOK 208.98 | 0.66% up | 51% up | ||
| 6 | Amneal PharmaceuticalsAMRX · Health Care | 2.5 | NOK 72.7B | NOK 208.79 | 2.24% down | 90% up | ||
| 7 | Bristol-Myers SquibbBMY · Health Care | 2.5 | NOK 1.16T | NOK 569.45 | 2.05% down | 30% up | ||
| 8 | PfizerPFE · Health Care | 2.5 | NOK 1.53T | NOK 268.82 | 1.85% down | 15% up | ||
| 9 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.6 | NOK 438.9B | NOK 376.19 | 8.74% down | 74% up | ||
| 10 | Elanco Animal HealthELAN · Health Care | 2.8 | NOK 128.3B | NOK 256.62 | 1.54% down | 26% up | ||
| 11 | PTC TherapeuticsPTCT · Health Care | 2.8 | NOK 47.6B | NOK 569.31 | 3.16% down | 21% down | ||
| 12 | Legend BiotechLEGN · Health Care | 3.0 | NOK 30.5B | NOK 157.15 | 0.92% down | 41% down | ||
| 13 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.5 | NOK 120.7B | NOK 144.76 | 1.00% down | 8% up | ||
| 14 | ZoetisZTS · Health Care | 3.5 | NOK 320.4B | NOK 788.59 | 5.59% down | 26% down | ||
| 15 | Jazz PharmaceuticalsJAZZ · Health Care | 3.6 | NOK 148.1B | NOK 2,307.98 | 4.57% down | 41% up | ||
| 16 | BioMarin PharmaceuticalBMRN · Health Care | 3.7 | NOK 116.1B | NOK 599.52 | 0.02% down | 17% up | ||
| 17 | Novo NordiskNVO · Health Care | 3.7 | NOK 1.67T | NOK 379.41 | 1.42% down | 17% down | ||
| 18 | Abbott LaboratoriesABT · Health Care | 4.1 | NOK 1.76T | NOK 1,013.87 | 0.58% down | 16% down | ||
| 19 | AstraZenecaAZN · Health Care | 4.6 | NOK 2.66T | NOK 1,712.17 | 1.87% down | 1% up | ||
| 20 | Ionis PharmaceuticalsIONS · Health Care | 4.8 | NOK 44.2B | NOK 265.69 | 0.62% down | 63% down | ||
| 21 | Merck & CoMRK · Health Care | 5.0 | NOK 3.2T | NOK 1,296.35 | 3.61% down | 45% up | ||
| 22 | NovartisNVS · Health Care | 5.2 | NOK 2.79T | NOK 1,476.05 | 2.57% down | 25% up | ||
| 23 | AlkermesALKS · Health Care | 5.3 | NOK 75.7B | NOK 450.76 | 1.43% down | 66% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | 5.3 | NOK 193.3B | NOK 1,442.87 | 1.06% down | 66% down | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | 6.7 | NOK 932.3B | NOK 9,012.68 | 2.35% down | 28% up | ||
| 26 | Johnson & JohnsonJNJ · Health Care | 6.8 | NOK 6.28T | NOK 2,607.54 | 2.04% down | 34% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | NOK 60.2B | NOK 426.07 | 1.25% up | 13% up | ||
| 28 | United TherapeuticsUTHR · Health Care | 7.5 | NOK 232.4B | NOK 5,457.35 | 3.16% down | 22% up | ||
| 29 | AbbVieABBV · Health Care | 8.2 | NOK 4.89T | NOK 2,767.62 | 0.86% down | 25% up | ||
| 30 | GenmabGMAB · Health Care | 8.5 | NOK 309.1B | NOK 501.23 | 0.75% up | 70% up | ||
| 31 | BeOne MedicinesONC · Health Care | 8.5 | NOK 445.6B | NOK 3,901.46 | 0.97% down | 16% up | ||
| 32 | Corcept TherapeuticsCORT · Health Care | 9.3 | NOK 69.4B | NOK 634.27 | 4.15% down | 10% down | ||
| 33 | Travere TherapeuticsTVTX · Health Care | 9.4 | NOK 45.3B | NOK 471.45 | 3.86% down | 45% up | ||
| 34 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | NOK 90B | NOK 3,872.56 | 0.34% down | 27% down | ||
| 35 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 10.8 | NOK 71.7B | NOK 912.99 | 1.59% down | 129% up | ||
| 36 | Vertex PharmaceuticalsVRTX · Health Care | 11.0 | NOK 1.29T | NOK 5,082.14 | 2.94% down | 27% up | ||
| 37 | Axsome TherapeuticsAXSM · Health Care | 11.2 | NOK 69.7B | NOK 1,324.37 | 1.25% up | 6% down | ||
| 38 | Mirum PharmaceuticalsMIRM · Health Care | 12.0 | NOK 60.9B | NOK 932.27 | 3.27% up | 34% up | ||
| 39 | TG TherapeuticsTGTX · Health Care | 15.9 | NOK 95.7B | NOK 633.29 | 1.88% down | 117% up | ||
| 40 | Royalty PharmaRPRX · Health Care | 16.4 | NOK 380.1B | NOK 661.01 | 1.38% down | 79% up | ||
| 41 | Eli LillyLLY · Health Care | 18.5 | NOK 11.75T | NOK 13,188.23 | 2.29% down | 33% up | ||
| 42 | Ascendis PharmaASND · Health Care | 21.0 | NOK 163.9B | NOK 2,498.42 | 5.32% down | 29% up | ||
| 43 | Ligand PharmaceuticalsLGND · Health Care | 21.4 | NOK 56B | NOK 2,800.81 | 3.94% down | 50% up | ||
| 44 | BridgeBio PharmaBBIO · Health Care | 30.3 | NOK 148.7B | NOK 763.11 | 0.22% up | 21% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | 42.7 | NOK 79B | NOK 1,140.08 | 1.88% down | 18% up | ||
| 46 | InsmedINSM · Health Care | 52.3 | NOK 309.3B | NOK 1,410.07 | 20.58% up | 40% down | ||
| 47 | CytokineticsCYTK · Health Care | 81.4 | NOK 70B | NOK 502.30 | 0.27% up | 19% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | 176 | NOK 79B | NOK 1,210.55 | 2.47% down | 51% up | ||
| 49 | Dianthus TherapeuticsDNTH · Health Care | 2346 | NOK 46.6B | NOK 828.02 | 1.01% up | 108% up | ||
| 50 | Roivant SciencesROIV · Health Care | 3418 | NOK 275.5B | NOK 380.29 | 0.59% up | 91% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7610 NOK). 11 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies have the lowest P/S ratio?
Grifols (0.7), Viatris (1.6) and GSK (2.2) have the lowest P/S ratio of the 50 health care pharmaceutical companies ranked here as of 20 Nov 2026, 03:47 UTC.
How many health care pharmaceutical companies are in this ranking?
50 are ranked by P/S ratio. 11 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 50 health care pharmaceutical companies ranked by P/S ratio have a combined market value of NOK 48.44T as of 20 Nov 2026, 03:47 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by P/S ratio”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.